Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H8FH
|
||||
Former ID |
DAP000498
|
||||
Drug Name |
Indapamide
|
||||
Synonyms |
Arifon; Bajaten; Cormil; Damide; Fludex; Idapamide; Indaflex; Indamol; Indapamida; Indapamidum; Ipamix; Lozide; Lozol; Metindamide; Natrilix; Natrix; Noranat; Pressurai; Tandix; Tertensif; Veroxil; RHC 2555; SE 1520; USV 2555; Apo-Indapamide; Indapamida [INN-Spanish]; Indapamide (USP); Indapamidum [INN-Latin]; Lozol (TN); Natrilix (TN); Natrix (TN); Novo-Indapamide; Nu-Indapamide; S-1520; SE-1520; Indapamide (JAN/USP); Indapamide [USAN:INN:BAN:JAN]; N-[4-Chloro-3-sulfamoylbenzamido]-2-methylindoline; NLozol, Arifon, Fludex, Noranat, Veroxil, Tertensif, Indapamide; N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline; Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-(9CI); 1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline; 3-(Aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide; 4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide; 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antihypertensive Agents
|
||||
Company |
Servier Laboratories
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H16ClN3O3S
|
||||
InChI |
InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)
|
||||
InChIKey |
NDDAHWYSQHTHNT-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 26807-65-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
855885, 7548663, 7847411, 7979602, 8149386, 8152339, 11335683, 11360922, 11363811, 11366373, 11368935, 11371494, 11373532, 11377097, 11461894, 11484755, 11488796, 11490283, 11491832, 11494731, 14828553, 24895952, 26611782, 26680433, 26747199, 26747200, 29222825, 46508626, 47216741, 47515281, 48184956, 48259190, 48259191, 48334450, 49698709, 49832093, 49876093, 56413189, 56422467, 57321947, 57654295, 80156605, 80953761, 85086931, 85148358, 85788440, 87561081, 92124043, 92307457, 92309252
|
||||
SuperDrug ATC ID |
C03BA11
|
||||
SuperDrug CAS ID |
cas=026807658
|
||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily KQT member 1 | Target Info | Blocker | [536209] | |
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | Voltage gated Potassium channels | ||||
References | |||||
Ref 538270 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 074299. | ||||
Ref 542217 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7203). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.